(NASDAQ: AEMD) Aethlon Medical's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.09%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.9%.
Aethlon Medical's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast AEMD's revenue for 2030 to be $23,050,567, with the lowest AEMD revenue forecast at $23,050,567, and the highest AEMD revenue forecast at $23,050,567.
In 2031, AEMD is forecast to generate $62,447,025 in revenue, with the lowest revenue forecast at $62,447,025 and the highest revenue forecast at $62,447,025.